| Literature DB >> 35794516 |
Takahiro Miyoshi1,2, Hideki Endo2, Hiroyuki Yamamoto3,4, Koki Shimada2, Hiraku Kumamaru1,5, Nao Ichihara1,5, Yoshiki Miyachi1, Hiroaki Miyata1,2,5.
Abstract
BACKGROUND: The risk of choking increases with aging, and the number of cases of choking-induced cardiac arrest is increasing. However, few studies have examined the prognosis of choking-induced cardiac arrest. The aim of this study was to reveal the rates of survival and dependence on devices in the long term after choking-induced cardiac arrest.Entities:
Keywords: Cardiac arrest; Choking; Clinical course; Long-term prognosis; Resuscitation
Mesh:
Year: 2022 PMID: 35794516 PMCID: PMC9258190 DOI: 10.1186/s12873-022-00676-8
Source DB: PubMed Journal: BMC Emerg Med ISSN: 1471-227X
Fig. 1Flow diagram showing of the inclusion-exclusion process
Characteristics of choking-induced cardiac arrest patients by age group
| Total | 20–64 years old | 65–74 years old | 75–84 years old | ≥85 years old | ||
|---|---|---|---|---|---|---|
| Age, median (IQR) | 85 (79–89) | 56.5 (51–62) | 70 (67–72) | 82 (80–83) | 89 (87–92) | |
| Men, n (%) | 144 (53.7%) | 16 (61.5%) | 17 (51.5%) | 47 (67.1%) | 64 (46.0%) | 0.027 |
| Antipsychotic use, n (%) | 62 (23.1%) | 15 (57.7%) | 15 (45.5%) | 14 (20.0%) | 18 (12.9%) | < 0.001 |
| Dopamine agonists use, n (%) | 25 (9.3%) | 0 (0.0%) | 2 (6.1%) | 13 (18.6%) | 10 (7.2%) | 0.017 |
| Anticholinergic agents use, n (%) | 42 (15.7%) | 8 (30.8%) | 7 (21.2%) | 15 (21.4%) | 12 (8.6%) | 0.004 |
| Sedative agents use, n (%) | 80 (29.9%) | 13 (50.0%) | 14 (42.4%) | 14 (20.0%) | 39 (28.1%) | 0.012 |
| Steroid use, n (%) | 13 (4.9%) | 0 (0.0%) | 1 (3.0%) | 5 (7.1%) | 7 (5.0%) | 0.64 |
| Dementia (with donepezil use), n (%) | 38 (14.2%) | 0 (0.0%) | 3 (9.1%) | 11 (15.7%) | 24 (17.3%) | 0.071 |
| Stroke, n (%) | 81 (30.2%) | 1 (3.8%) | 8 (24.2%) | 28 (40.0%) | 44 (31.7%) | 0.002 |
| Sjogren’s syndrome, n (%) | 5 (1.9%) | 0 (0.0%) | 2 (6.1%) | 3 (4.3%) | 0 (0.0%) | 0.025 |
| Daily life independence level, n (%) | ||||||
| Unrated | 99 (36.9%) | 25 (96.2%) | 17 (51.5%) | 26 (37.1%) | 31 (22.3%) | < 0.001 |
| Independence | 64 (23.9%) | 0 (0.0%) | 9 (27.3%) | 19 (27.1%) | 36 (25.9%) | |
| Dependence | 105 (39.2%) | 1 (3.8%) | 7 (21.2%) | 25 (35.7%) | 72 (51.8%) | |
| Nursing home, n (%) | 15 (5.6%) | 0 (0.0%) | 1 (3.0%) | 4 (5.7%) | 10 (7.2%) | 0.62 |
| State of dysphagia (within 12 months) | ||||||
| Dysphagia rehabilitation, n (%) | 14 (5.2%) | 1 (3.8%) | 0 (0.0%) | 4 (5.7%) | 9 (6.5%) | 0.58 |
| Aspiration pneumonia, n (%) | 21 (7.8%) | 1 (3.8%) | 1 (3.0%) | 5 (7.1%) | 14 (10.1%) | 0.59 |
| Procedure after cardiac arrest | ||||||
| TTM, n (%) | 1 (0.4%) | 0 (0.0%) | 0 (0.0%) | 1 (1.4%) | 0 (0.0%) | 0.48 |
| Tracheostomy, n (%) | 13 (4.9%) | 1 (3.8%) | 6 (18.2%) | 3 (4.3%) | 3 (2.2%) | 0.005 |
| Gastrostomy, n (%) | 1 (0.4%) | 0 (0.0%) | 0 (0.0%) | 1 (1.4%) | 0 (0.0%) | 0.48 |
| Dysphagia Rehabilitation, n (%) | 8 (3.0%) | 0 (0.0%) | 1 (3.0%) | 3 (4.3%) | 4 (2.9%) | 0.89 |
| Survival after cardiac arrest, n (%) | ||||||
| 1 month following cardiac arrest, n (%) | 36 (13.4%) | 2 (7.7%) | 9 (27.3%) | 9 (12.9%) | 16 (11.5%) | 0.12 |
| 3 months following cardiac arrest, n (%) | 15 (5.6%) | 1 (3.8%) | 5 (15.2%) | 6 (8.6%) | 3 (2.2%) | 0.013 |
| 12 months following cardiac arrest, n (%) | 7 (2.6%) | 0 (0.0%) | 3 (9.1%) | 3 (4.3%) | 1 (0.7%) | 0.028 |
Abbreviations: IQR interquartile range, TTM targeted temperature management, CA cardiac arrest
Fig. 2Number of choking-induced cardiac arrests by month from April 2012 to September 2018. The numbers of incidents in November to March were higher than those in the other months
Fig. 3Kaplan-Meier survival curves for each age group at 12 months after choking-induced cardiac arrest. In all age groups, over 80% of choking-induced cardiac arrest patients died within 3 months after choking-induced cardiac arrest
Comparisons between nonsurvivors and survivors at 3 months after cardiac arrest
| Total | Nonsurvivor | Survivor | ||
|---|---|---|---|---|
| Age, median (IQR) | 85 (79–89) | 85 (80–89) | 78 (68–84) | 0.006 |
| Men, n (%) | 144 (53.7%) | 136 (53.8%) | 8 (53.3%) | 1.00 |
| Antipsychotic use, n (%) | 62 (23.1%) | 55 (21.7%) | 7 (46.7%) | 0.051 |
| Dopamine agonists use, n (%) | 25 (9.3%) | 22 (8.7%) | 3 (20.0%) | 0.15 |
| Anticholinergic agents use, n (%) | 42 (15.7%) | 37 (14.6%) | 5 (33.3%) | 0.067 |
| Sedative agents use, n (%) | 80 (29.9%) | 75 (29.6%) | 5 (33.3%) | 0.78 |
| Steroid use, n (%) | 13 (4.9%) | 12 (4.7%) | 1 (6.7%) | 0.54 |
| Dementia (with donepezil use), n (%) | 38 (14.2%) | 36 (14.2%) | 2 (13.3%) | 1.00 |
| Stroke, n (%) | 81 (30.2%) | 76 (30.0%) | 5 (33.3%) | 0.78 |
| Sjogren’s syndrome, n (%) | 5 (1.9%) | 5 (2.0%) | 0 (0.0%) | 1.00 |
| Daily life independence level, n (%) | ||||
| Unrated | 99 (36.9%) | 93 (36.8%) | 6 (40.0%) | 0.89 |
| Independence | 64 (23.9%) | 60 (23.7%) | 4 (26.7%) | |
| Dependence | 105 (39.2%) | 100 (39.5%) | 5 (33.3%) | |
| Nursing home, n (%) | 15 (5.6%) | 15 (5.9%) | 0 (0.0%) | 1.00 |
| State of dysphagia (within 12 months) | ||||
| Dysphagia rehabilitation, n (%) | 14 (5.2%) | 14 (5.5%) | 0 (0.0%) | 1.00 |
| Aspiration pneumonia, n (%) | 21 (7.8%) | 20 (7.9%) | 1 (6.7%) | 1.00 |
Abbreviations: IQR interquartile range
Comparisons between ventilator-dependent and nonventilator-dependent patients at 3 months
| Total | Nonventilator dependent | Ventilator dependent | ||
|---|---|---|---|---|
| Age, median (IQR) | 78 (68–84) | 78 (70–81) | 76 (66–86) | 0.95 |
| Men, n (%) | 8 (53%) | 5 (56%) | 3 (50%) | 1.00 |
| TTM, n (%) | 1 (7%) | 1 (11%) | 0 (0%) | 1.00 |
| Tracheostomy, n (%) | 8 (53%) | 3 (33%) | 5 (83%) | 0.12 |
| Gastrostomy, n (%) | 1 (7%) | 1 (11%) | 0 (0%) | 1.00 |
| Dysphagia rehabilitation, n (%) | 2 (13%) | 2 (22%) | 0 (0%) | 0.49 |
| Tube feeding at 3 months, n (%) | 9 (60%) | 4 (44%) | 5 (83%) | 0.29 |
| Central venous catheter at 3 months, n (%) | 4 (27%) | 1 (11%) | 3 (50%) | 0.24 |
| Survival in the 12 months, n (%) | 7 (47%) | 4 (44%) | 3 (50%) | 1.00 |
| Survival month, median (IQR) | 17 (5–29) | 29 (5–38) | 8 (7–17) | 0.72 |
Abbreviations: IQR interquartile range, TTM targeted temperature management, CVC central venous catheter